LEGAL HELP
Deadline · Time limits may apply

Facing a DOH, MOHAP or DHA Inspection Finding, Show-Cause Notice or Licence Suspension

“My clinic has received an inspection finding, a show-cause notice, or a licence suspension from DOH, MOHAP or DHA — or I'm a doctor, nurse or pharmacist facing one myself — and I don't know what my options or deadlines are.”

A regulatory inspection finding, show-cause notice or licence suspension from DOH, MOHAP or DHA is an administrative enforcement action against your facility's or your own professional licence — a separate legal track from a patient's medical malpractice claim, which runs through the Medical Liability Committee process instead.

If you run or work at a clinic, hospital or pharmacy — or you're a doctor, nurse or pharmacist yourself — and an inspection finding, a show-cause notice, or a suspension has landed on your desk, this page is about your side of it: the facility's or practitioner's standing with its regulator, not a patient's claim against you. LEXNOVA is a UAE lawyer-matching service — not a law firm — and this page doesn't give legal advice or predict how your specific case will go. It sets out what DOH, MOHAP and DHA's own published material actually says as of 23 September 2026, and is explicit about the real gaps in what's publicly confirmed, rather than smoothing them over to make the three regulators look more alike than their own material shows.

LAST REVIEWED 23 SEPTEMBER 2026

WHERE THIS IS HANDLED

DOH's internal Appeal Committee (Chapter XII of its Healthcare Regulator Manual) for Abu Dhabi; DHA's 'Appeal Violations' e-service on the Sheryan portal for Dubai outside DHCC; MOHAP's Health Practices Control Committee, reached via MOHAP's complaints intake, for the Northern Emirates; and DHCA's own, separate process for Dubai Healthcare City, which this page does not cover. Whether any of these internal routes can be followed by a further challenge before the UAE's ordinary courts is not established in the material reviewed for this page — that's a question for a lawyer, not an assumption this page makes either way.

How the answer changes by jurisdiction

  • Abu Dhabi mainland (DOH)

    Your primary regulator is the Department of Health – Abu Dhabi (DOH). DOH's own material cites two different establishing laws — its Healthcare Regulator Manual points to Law No. 1 of 2007 (the original Health Authority – Abu Dhabi), while its facility-licensure standard and the Abu Dhabi Official Gazette point to Law No. 10 of 2018 (the Department of Health). The most defensible reading is that HAAD was reconstituted as DOH under the 2018 law, but DOH's own manuals haven't been fully harmonised on this, and the precise legal mechanism connecting the two instruments isn't independently confirmed — don't be surprised if a notice or a lawyer cites one rather than the other.

  • Dubai, outside Dubai Healthcare City (DHA)

    Your primary regulator is the Dubai Health Authority (DHA), operating under Law No. 6 of 2018 as amended by DHA Law No. 14 of 2021. DHA's constitutive law gives it audit and inspection powers over facilities and professionals, but delegates the actual penalty schedule, show-cause procedure and appeal mechanism to Director-General resolutions this research didn't locate. What DHA does publish clearly is its 'Appeal Violations' e-service — the single most concrete procedural anchor found for any of the three regulators (see Step 5).

  • Northern Emirates and federally-run facilities (MOHAP)

    If your facility is a private health or pharmaceutical establishment in Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah or Fujairah — or a federally-run facility — your primary regulator is the Ministry of Health and Prevention (MOHAP), acting under Federal Law No. 4 of 2015 on Private Health Facilities and its Cabinet Resolution No. 29 of 2020 executive regulations. MOHAP's own site names and hosts both instruments, but their article-level text wasn't retrievable in this research — treat any specific article number, fine figure or deadline attributed to either law as unconfirmed unless your own lawyer has read the text directly. MOHAP's federal remit means this same framework applies uniformly across all five Northern Emirates, rather than each one running its own separate scheme.

  • Dubai Healthcare City (DHCC) — a separate regime, not covered here

    If your facility is physically located inside Dubai Healthcare City, DHA is not your regulator, whatever your address might suggest. DHCC has its own regulator, the Dubai Healthcare City Authority (DHCA), with its own complaint-management policy — a genuinely separate regime this page does not cover in any detail. If your notice mentions healthcare regulation in Dubai, check which authority actually issued it before assuming DHA's Appeal Violations process (Step 5) applies to you.

STEP 01

Work out which regulator actually issued your notice — don't assume from your address alone

DOH, MOHAP and DHA are three genuinely separate regulators, not regional branches of one body, and the notice you've received will have come from exactly one of them, with its own procedure and its own possible deadlines. Read the letterhead and the issuing authority's name carefully rather than assuming based only on which emirate you're in.

One specific trap worth flagging: if your facility sits inside Dubai Healthcare City, DHA is not your regulator. DHCC has its own authority, the Dubai Healthcare City Authority (DHCA), with its own process that this page does not cover — don't apply DHA's appeal mechanics (Step 5) to a DHCC notice.

STEP 02

Read the notice for what it actually says — and what it doesn't

None of the three regulators' published material reviewed for this page sets out a single, itemised violation-classification or fixed-fine schedule for an ongoing compliance inspection of an already-operating facility. What each regulator does publish is a general sanctions structure, and for DHA specifically, a genuinely concrete appeal process — so whatever figures matter to your case will be in your own notice, not in a general schedule you could have looked up in advance.

If your notice doesn't state a response deadline, don't assume there isn't one, and don't assume a standard figure applies. For DOH specifically, the 'Notice of Sanction' provision in its own manual requires written notice and reasons but does not itself state a number of days to respond — this page can't fill that gap in on DOH's behalf, and neither should anyone else without checking further.

STEP 03

If DOH issued your notice: the sanctions ladder and the Appeal Committee

DOH's Healthcare Regulator Manual sets out a hierarchy of sanctions — formal censure or warning, variation of licence conditions, suspension or revocation of a licence or authorisation, corrective directions, and undertakings DOH may accept instead of, or alongside, a sanction. DOH's real enforcement announcements cite specific articles of its 'Disciplinary Regulations Governing the Healthcare Sector,' updated November 2024 — these article numbers don't map onto the 2017 Manual's own chapter numbering, so treat DOH's framework as layered rather than a single code, and don't assume a lawyer citing one document is wrong just because it doesn't match another.

DOH's Manual also devotes an entire chapter — Chapter XII, 'Appeals' — to an internal review body it calls 'the Committee,' with a confirmed right to seek an appeal, formal Appeal Rules, a 'Permission' step, Interim Measures pending the outcome, and a Notice of Determination. What DOH's own material does not state, in the sections available for this page, is any specific appeal-filing deadline, any fee, or the Committee's composition — treat any confident number for these as unverified until your own lawyer confirms it.

STEP 04

If MOHAP issued your notice: understand the administrative/medical fork

MOHAP's own complaints process forks at intake. An inspection-related administrative complaint against your facility is routed toward its Health Practices Control Committee; a complaint about the medical care itself goes to the separate Medical Liability Committee — the patient malpractice track, not this one. MOHAP states a standard completion timeline of 45 days for its complaints process generally, but its own pages don't spell out a specific penalty menu, and the Health Practices Control Committee's internal procedure, composition and any deadlines aren't described in the material available for this page.

Don't confuse MOHAP's engineering inspection service for a new or renewing facility licence — a 7-to-10-working-day process with escalating AED 2,000/5,000 repeat-visit fees — with an enforcement inspection of a facility that's already operating. They're two different MOHAP processes with different purposes, and a notice connected to one tells you nothing reliable about the other.

STEP 05

If DHA issued your notice: the one confirmed, concrete deadline in this whole area

This is the clearest procedural anchor found anywhere in DOH, MOHAP or DHA's own published material reviewed for this page: DHA's 'Appeal Violations' e-service on the Sheryan portal lets a Delegated Healthcare Facility Representative appeal a violation within 30 days of it being issued, with a review that takes DHA approximately 30 working days before a determination is communicated. The service is free of charge, but a given violation can be appealed only once, and an incomplete or inactive application is auto-deleted after 3 months, with a 15-day warning notice sent beforehand first.

This 30-day window is specific to DHA. It is not confirmed to apply to a DOH Appeal Committee filing or a MOHAP Health Practices Control Committee matter — don't import DHA's deadline into a DOH or MOHAP situation just because it's the most concrete figure available anywhere on this page. And DHA's description of its single internal appeal as 'final and non-revisable' is about that internal process only — it says nothing, one way or the other, about whether you can separately challenge the decision before Dubai's courts afterward.

STEP 06

Don't assume what happens after the internal appeal, for any of the three regulators

Whether a DOH Appeal Committee determination, a MOHAP committee finding, or an exhausted DHA appeal decision can be taken further to the UAE's ordinary civil or administrative courts is not established in any of the three regulators' own material reviewed for this page. This is a genuine, open question for a lawyer to answer for your specific situation — treat anyone who confidently tells you there is, or isn't, a further court route as getting ahead of what's actually published.

Publicity is similarly unsettled. DOH's own Manual commits, on paper, to publishing sanction notices and appeal determinations 'in such manner as it considers appropriate,' yet the real DOH enforcement releases reviewed for this page described violations and actions taken without naming the facilities involved. MOHAP's and DHA's published material is silent on this point entirely. Raise the question of whether your case could become public with your lawyer early, rather than assuming either way.

STEP 07

Get a healthcare-regulatory lawyer involved before you respond substantively

Where a confirmed deadline exists — DHA's 30-day appeal window is the clear example — missing it forecloses your only route of internal review, since a violation can be appealed only once. Where no deadline is confirmed, such as DOH's Notice of Sanction, that's exactly the situation where getting advice early matters most, because you're working out a sensible timeline for yourself rather than following a published one.

A facility's or practitioner's response to a regulatory finding can affect its licensing status well beyond the specific issue raised, and this calls for a different skill set from defending a patient malpractice claim. You want a lawyer who actually works the administrative/regulatory side of DOH, MOHAP or DHA — not one whose healthcare experience sits mainly on the medical liability committee track.

START YOUR REQUEST

Tell Us About Your Situation.

The matter type is already set to Healthcare Regulatory & Licensing, so the form begins with your location. LEXNOVA is a lawyer-matching service, not a law firm — any legal advice comes directly from the independent legal professional you are connected with.

Step 2 of 540%

Where is your matter located?

FAQ

No — LEXNOVA is a UAE lawyer-matching service, not a law firm. It does not give legal advice, does not represent facilities or practitioners before any regulator, and cannot predict how your case will be decided. LEXNOVA Legal Connect can help you describe your situation and find a lawyer who handles DOH, MOHAP or DHA regulatory matters.

This page covers your facility's or your own standing with its regulator — an inspection finding, a show-cause notice, a licence action. A malpractice claim is a patient's allegation of harm from treatment, which runs through the separate Medical Liability Committee process, not the licensing/enforcement track described here. The same incident can in principle trigger both, but facing one doesn't mean you're facing the other.

It depends on where you're physically located: DOH for Abu Dhabi, DHA for Dubai outside Dubai Healthcare City, and MOHAP for private facilities in the Northern Emirates (Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, Fujairah) and federally-run facilities. Dubai Healthcare City is a further exception, regulated separately by the Dubai Healthcare City Authority, not DHA.

No. Facilities and professionals physically located in Dubai Healthcare City are regulated by the Dubai Healthcare City Authority (DHCA), a separate body from DHA with its own complaint-management policy. This page does not cover DHCA's process — check your notice's issuing authority before assuming DHA's 30-day Appeal Violations window applies to you.

DOH's own material isn't fully consistent on this. Its Healthcare Regulator Manual cites Law No. 1 of 2007, establishing the Health Authority – Abu Dhabi, while its facility-licensure standard and the Abu Dhabi Official Gazette cite Law No. 10 of 2018, establishing the Department of Health. The most defensible reading is that the 2007 body was reconstituted as DOH under the 2018 law, but the precise legal mechanism connecting the two hasn't been independently confirmed.

MOHAP's own site names Federal Law No. 4 of 2015 on Private Health Facilities as the licensing law, with Cabinet Resolution No. 29 of 2020 as its executive regulations. Both instruments' titles and existence are confirmed, but their article-level text — including any specific fine figures or deadlines — could not be retrieved in this research and shouldn't be assumed.

Thirty days from when the violation was issued, filed through DHA's "Appeal Violations" e-service on the Sheryan portal. The review itself then takes DHA approximately 30 working days before a determination is communicated. The service is free, but a given violation can only be appealed once.

This isn't confirmed either way. DOH's Healthcare Regulator Manual describes an internal Appeal Committee (Chapter XII) with formal Appeal Rules, but no specific filing deadline, fee or committee composition was stated in the material reviewed for this page — don't assume DHA's 30-day figure carries over to a DOH matter.

DHA's own service description doesn't spell out the consequence of a late filing in the material reviewed for this page, but given that a violation can be appealed only once and the window is stated as a firm 30 days, treating it as a genuine deadline — not a soft guideline — is the safer approach. Involve a lawyer well before day 30 if you intend to appeal.

This isn't established in any of the three regulators' own published material reviewed for this page. DHA describes its single internal appeal as 'final and non-revisable,' but that language is about the internal process only — it doesn't say whether a further court challenge is available. The same open question applies to a DOH Appeal Committee determination and a MOHAP committee finding. Put this directly to a lawyer rather than assuming either way.

The picture is genuinely mixed. DOH's own Manual commits, on paper, to publishing sanction notices and appeal determinations, but its recent enforcement press releases described violations and actions taken without naming the facilities involved. MOHAP's and DHA's published material doesn't address publicity of individual cases at all. Whether your specific case becomes public isn't something this page can tell you either way — raise it with a lawyer early.

DOH's Healthcare Regulator Manual sets out a hierarchy: formal censure or warning, variation of licence conditions, suspension or revocation of a licence or authorisation, corrective directions, and undertakings DOH may accept instead of or alongside a sanction. DOH must give written notice stating the sanction and its reasons, though the Manual doesn't itself state a response deadline.

MOHAP's process forks at intake: an inspection-related administrative complaint is routed toward its Health Practices Control Committee, while a complaint about the medical care itself goes to the separate Medical Liability Committee — a different legal track entirely. MOHAP states a standard 45-day completion timeline for its complaints process generally, but doesn't spell out a specific penalty menu on the pages reviewed for this page.

No, and this is a common point of confusion. MOHAP's engineering inspection is a pre-licensing service for a new or renewing facility licence — quoted at 7 to 10 working days, with the first visit free and escalating AED 2,000/5,000 fees for repeat visits. It's a different process from an enforcement inspection of an already-operating facility, and a notice from one tells you nothing about the other.

No general, fixed AED fine schedule or violation-classification/points system for an ongoing compliance inspection of an already-operating facility was found in any of the three regulators' published material for this page. One confirmed, but different, DOH figure is a late-renewal delay fine — 25% of the established licensing fee, charged monthly for up to 6 months — but that's a licensing-renewal fine, not a violation penalty.

DOH's own 2025 year-in-review news item reports 4,540 licensing audit rounds, 223 violations issued, and 7 facility closures in 2025, alongside a 98% closure rate on complaint cases. MOHAP's most recent published aggregate figures found for this page date from 2017 — 27 medical and 15 pharmaceutical establishment closures that year. Both are real, dated figures useful as context, not a prediction of what will happen in any individual case, including yours.

For DOH, yes — its Healthcare Regulator Manual applies the same general audit and appeal machinery, Chapters XI and XII, to Facility Research Authorisation breaches as to any other compliance issue. Whether MOHAP or DHA treat clinical-trial or research-authorisation breaches the same way, or through a separate track, isn't established in the material available for this page.

Yes, in principle. DOH, MOHAP and DHA each license individual practitioners as well as facilities, and the inspection, sanction and appeal mechanics described on this page relate to practitioner licensing action too, not just facility-level action. The specific regulator and process still depend on where you're licensed to practise, following the same jurisdiction breakdown as for a facility.

LEXNOVA is not a law firm and does not provide legal advice, legal opinions, legal representation, or legal services. Any legal advice or representation is provided directly by the independent legal professional engaged by the client.

A connection or introduction does not constitute a guarantee, endorsement, or assurance of outcome. Users should independently confirm the professional's qualifications, authorization, fees, scope of engagement, and suitability.

NEED HELP WITH YOUR OWN SITUATION?

This page is general information — your situation is specific.

Find a Lawyer